Boston Scientific Corporation
BSX
$73.85
-$2.37-3.11%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.90B | 2.79B | 2.51B | 2.03B | 1.85B |
| Total Depreciation and Amortization | 1.37B | 1.35B | 1.32B | 1.29B | 1.27B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 514.00M | 561.00M | 420.00M | 887.00M | 775.00M |
| Change in Net Operating Assets | -246.00M | -77.00M | 45.00M | -397.00M | -462.00M |
| Cash from Operations | 4.53B | 4.63B | 4.29B | 3.81B | 3.44B |
| Capital Expenditure | -876.00M | -802.00M | -800.00M | -798.00M | -790.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1.59B | -4.92B | -5.79B | -4.83B | -4.64B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -171.00M | -108.00M | -164.00M | -272.00M | -257.00M |
| Cash from Investing | -2.64B | -5.83B | -6.76B | -5.90B | -5.69B |
| Total Debt Issued | 1.56B | 1.75B | 1.75B | 1.75B | 2.33B |
| Total Debt Repaid | -2.05B | -1.84B | -1.63B | -1.31B | -529.00M |
| Issuance of Common Stock | 282.00M | 290.00M | 271.00M | 265.00M | 230.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -186.00M | -192.00M | -277.00M | -221.00M | -219.00M |
| Cash from Financing | -395.00M | 3.00M | 114.00M | 478.00M | 1.81B |
| Foreign Exchange rate Adjustments | 42.00M | 30.00M | 38.00M | 35.00M | -11.00M |
| Miscellaneous Cash Flow Adjustments | -- | -1.00M | -2.00M | -1.00M | -1.00M |
| Net Change in Cash | 1.54B | -1.17B | -2.32B | -1.58B | -450.00M |